{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T13:26:29Z","timestamp":1790774789679,"version":"4.1.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["OARRR"],"DOI":"10.2147\/oarrr.s14569","type":"journal-article","created":{"date-parts":[[2012,5,7]],"date-time":"2012-05-07T23:42:22Z","timestamp":1336434142000},"page":"33","source":"Crossref","is-referenced-by-count":12,"title":["The role of adalimumab in rheumatic and autoimmune disorders: comparison with other biologic agents"],"prefix":"10.2147","author":[{"given":"Andreas","family":"Reimold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2012,5]]},"container-title":["Open Access Rheumatology: Research and Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=12686","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T18:14:29Z","timestamp":1477851269000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/the-role-of-adalimumab-in-rheumatic-and-autoimmune-disorders-compariso-peer-reviewed-article-OARRR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/oarrr.s14569","relation":{},"ISSN":["1179-156X"],"issn-type":[{"value":"1179-156X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}